|Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.||
Big Pharma? Think Again
The author of this piece, the CEO of a small, publicly traded biotech company, argues that biotech companies are spending billions of dollars in R & D each year and that these sums will not be supplied by the investors who are currently footing the bill if they are afraid they cannot make their money back from drug profits. He cautions policy makers to “first do no harm” when they think about intervening in the drug markets.
|home spotlight commentary research events news about contact links archives|